Medical Device | April 05, 2022
Agilent joins AMBIC to advance biomanufacturing
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Announces pilot project for rapid, remote diagnosis of tuberculosis
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Trescal provides precision calibration expertise in every industry, geography and instrument across the world
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
It is currently available in tablet and injectable dosage forms
The two-day event will showcase achievements and address issues pertaining to the industry
Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
Subscribe To Our Newsletter & Stay Updated
